Shares of Doximity, Inc. (NYSE:DOCS – Get Free Report) have earned an average rating of “Buy” from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, two have given a buy recommendation and three have issued a strong buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $55.00.
Several research firms recently issued reports on DOCS. Wells Fargo & Company raised shares of Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 price target on the stock in a report on Tuesday, January 20th. Royal Bank Of Canada raised shares of Doximity to a “moderate buy” rating in a research report on Thursday, January 8th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Doximity in a research report on Wednesday, December 24th. Truist Financial upgraded Doximity from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 8th. Finally, Zacks Research upgraded Doximity from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 26th.
Get Our Latest Stock Analysis on DOCS
Doximity Stock Performance
About Doximity
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
See Also
- Five stocks we like better than Doximity
- Your Bank Account Is No Longer Safe
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
- They just tried to kill gold
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
